Correlation Between AIM ImmunoTech and DG Innovate

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AIM ImmunoTech and DG Innovate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AIM ImmunoTech and DG Innovate into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AIM ImmunoTech and DG Innovate PLC, you can compare the effects of market volatilities on AIM ImmunoTech and DG Innovate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AIM ImmunoTech with a short position of DG Innovate. Check out your portfolio center. Please also check ongoing floating volatility patterns of AIM ImmunoTech and DG Innovate.

Diversification Opportunities for AIM ImmunoTech and DG Innovate

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between AIM and DGI is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding AIM ImmunoTech and DG Innovate PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DG Innovate PLC and AIM ImmunoTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AIM ImmunoTech are associated (or correlated) with DG Innovate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DG Innovate PLC has no effect on the direction of AIM ImmunoTech i.e., AIM ImmunoTech and DG Innovate go up and down completely randomly.

Pair Corralation between AIM ImmunoTech and DG Innovate

Assuming the 90 days trading horizon AIM ImmunoTech is expected to under-perform the DG Innovate. But the stock apears to be less risky and, when comparing its historical volatility, AIM ImmunoTech is 1.15 times less risky than DG Innovate. The stock trades about -0.12 of its potential returns per unit of risk. The DG Innovate PLC is currently generating about 0.37 of returns per unit of risk over similar time horizon. If you would invest  6.30  in DG Innovate PLC on August 30, 2024 and sell it today you would earn a total of  4.70  from holding DG Innovate PLC or generate 74.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy91.3%
ValuesDaily Returns

AIM ImmunoTech  vs.  DG Innovate PLC

 Performance 
       Timeline  
AIM ImmunoTech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AIM ImmunoTech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
DG Innovate PLC 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in DG Innovate PLC are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, DG Innovate exhibited solid returns over the last few months and may actually be approaching a breakup point.

AIM ImmunoTech and DG Innovate Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AIM ImmunoTech and DG Innovate

The main advantage of trading using opposite AIM ImmunoTech and DG Innovate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AIM ImmunoTech position performs unexpectedly, DG Innovate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DG Innovate will offset losses from the drop in DG Innovate's long position.
The idea behind AIM ImmunoTech and DG Innovate PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk